Albert Seymour

Insider Reports History

Location
Bedford, MA
Signature
/s/ Paul Alloway, Attorney-in-Fact for Albert Seymour
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Albert Seymour:

Company Role Class Num Shares Value Price $ Report Date Ownership
Homology Medicines, Inc. President and Chief Executive Officer, Director Employee Stock Option (Right to Buy) 632,000 $8,481,440 $13.42 23 Feb 2023 Direct
Homology Medicines, Inc. President and Chief Executive Officer, Director Common Stock 150,874 $85,395 $0.5660 06 Sep 2023 Direct
Homology Medicines, Inc. President and Chief Executive Officer, Director Restricted Stock Units 9,380 $10,789 $1.15 06 Sep 2023 Direct

Insider Reports Filed by Albert Seymour

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FIXX Homology Medicines, Inc. 06 Sep 2023 3 -$1,665 4 President and Chief Executive Officer, Director 08 Sep 2023, 17:44
FIXX Homology Medicines, Inc. 23 Feb 2023 2 $0 4 President and Chief Executive Officer, Director 27 Feb 2023, 15:05
FIXX Homology Medicines, Inc. 09 Jan 2023 0 $0 4/A President and Chief Executive Officer, Director 20 Jan 2023, 15:05
FIXX Homology Medicines, Inc. 01 Jan 2023 4 $0 4 President and Chief Executive Officer, Director 04 Jan 2023, 15:35
FIXX Homology Medicines, Inc. 06 Sep 2022 2 $0 4 President and Chief Executive Officer Exhibit 24 - Power of Attorney, Director 08 Sep 2022, 16:05
FIXX Homology Medicines, Inc. 21 Apr 2022 1 $0 4 President and Chief Scientific Officer 21 Apr 2022, 17:31
FIXX Homology Medicines, Inc. 24 Feb 2022 2 $0 4 Chief Scientific Officer 28 Feb 2022, 15:05
FIXX Homology Medicines, Inc. 01 Jan 2022 3 -$6,279 4 Chief Scientific Officer 12 Jan 2022, 15:05